Teladoc Inc (NYSE:TDOC) Director Michael Goldstein sold 66,574 shares of the business’s stock in a transaction dated Friday, March 2nd. The stock was sold at an average price of $39.72, for a total value of $2,644,319.28. Following the sale, the director now owns 54,325 shares in the company, valued at approximately $2,157,789. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Teladoc Inc (NYSE TDOC) traded up $0.12 during mid-day trading on Wednesday, reaching $42.95. The company’s stock had a trading volume of 1,030,000 shares, compared to its average volume of 1,120,000. The company has a quick ratio of 3.87, a current ratio of 3.87 and a debt-to-equity ratio of 0.37. Teladoc Inc has a 52 week low of $20.85 and a 52 week high of $44.65. The firm has a market cap of $2,600.00 and a price-to-earnings ratio of -20.65.
Hedge funds and other institutional investors have recently modified their holdings of the company. SG Americas Securities LLC acquired a new stake in shares of Teladoc during the 4th quarter worth about $101,000. Montag A & Associates Inc. acquired a new position in Teladoc during the fourth quarter worth approximately $200,000. Raymond James Financial Services Advisors Inc. acquired a new position in Teladoc during the second quarter worth approximately $202,000. Xact Kapitalforvaltning AB acquired a new position in Teladoc during the fourth quarter worth approximately $203,000. Finally, Buckley Wealth Management LLC acquired a new position in Teladoc during the fourth quarter worth approximately $221,000.
TDOC has been the topic of several recent research reports. Deutsche Bank initiated coverage on Teladoc in a research report on Friday, December 8th. They issued a “buy” rating and a $39.00 price objective on the stock. Canaccord Genuity set a $42.00 price objective on Teladoc and gave the stock a “buy” rating in a research report on Friday, November 17th. Jefferies Group initiated coverage on Teladoc in a research note on Friday, January 26th. They set a “buy” rating and a $40.00 target price for the company. BidaskClub downgraded Teladoc from a “hold” rating to a “sell” rating in a research note on Wednesday, November 15th. Finally, Citigroup began coverage on Teladoc in a research note on Thursday, January 4th. They issued a “buy” rating for the company. One analyst has rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the company. Teladoc currently has a consensus rating of “Buy” and an average target price of $40.71.
TRADEMARK VIOLATION NOTICE: “Teladoc Inc (NYSE:TDOC) Director Michael Goldstein Sells 66,574 Shares” was published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.thelincolnianonline.com/2018/03/14/teladoc-inc-tdoc-director-sells-2644319-28-in-stock.html.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.